PRLD Market Cap & Key Metrics
Prelude Therapeutics Incorporated
$3.26
-$0.06(-1.81%)
40
Overall
60
Value
27
Tech
34
Quality
Market Cap
$264.95M
Volume
479.27K
52W Range
$1.16 - $6.83
Target Price
$9.00
PRLD market cap is $264.95M. This page lists Prelude Therapeutics Incorporated's P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
PRLD Key Metrics
- Market cap
- $264.95M
- EPS estimate, current year
- $-0.61
- EPS growth, 3-year
- +19.14%
- Value score
- 60
- Quality score
- 34
- Technical score
- 27
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $12.14M | $7.00M | - | - | - |
| EBITDA | -$96.25M | -$123.81M | -$118.73M | -$122.22M | -$112.82M |
| EPS | $-1.29 | $-1.68 | $-2.02 | $-2.44 | $-2.43 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | PRLD | $3.26 | -1.8% | 479.27K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Prelude Therapeutics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW